Kolexia
Kaltenbach Sophie
Pharmacien
Hôpital Necker Enfants Malades
Paris, France
72 Activités
171 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Lymphome B Transformation cellulaire néoplasique Syndromes myélodysplasiques Leucémie aigüe myéloïde Lymphome à cellules du manteau Lymphome T Prédisposition génétique à une maladie

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

-Related Disorders: From Disease Mechanism to Evidence-Based Treatments.
Annual review of genomics and human genetics   05 février 2024
Identification of TP53 aberrations in chronic lymphocytic leukaemia using different molecular diagnostic techniques
PATHOLOGY UPDATE 2024 ABSTRACTS SUPPLEMENT   01 février 2024
Optical Genome Mapping Provides New Molecular Insights in High-Risk Mantle Cell Lymphoma: A Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
RCHOP Plus High-Dose Methotrexate As First-Line Therapy in Large B-Cell Lymphoma with Testis Involvement
65th ASH Annual Meeting Abstracts   02 novembre 2023
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma.
Blood advances   20 octobre 2023
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition.
The Journal of experimental medicine   15 septembre 2023
Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France.
HemaSphere   24 août 2023
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study.
Haematologica   17 août 2023
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2.
Molecular cancer   10 juillet 2023
Brigatinib in patients with ALK-positive anaplastic large cell lymphoma who have failed brentuximab vedotin
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023